Cargando…
FAM83B inhibits ovarian cancer cisplatin resistance through inhibiting Wnt pathway
Cisplatin resistance is frequently occurred in ovarian cancer therapy, understanding its regulatory mechanisms is critical for developing novel treatment methods and drugs. Here, we found ovarian cancer patients with low FAM83B levels had shorter survival time, tissues with cisplatin resistance also...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797002/ https://www.ncbi.nlm.nih.gov/pubmed/33423038 http://dx.doi.org/10.1038/s41389-020-00301-y |